Literature DB >> 2950865

Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens.

N E Goeders, M J Kuhar.   

Abstract

A variety of clinical and animal data suggest that the repeated administration of cocaine and related psychomotor stimulants may be associated with a behavioral sensitization whereby the same dose of the drug results in increasing behavioral pathology. This investigation was designed to determine the effects of chronic cocaine administration on the binding of [3H]sulpiride, a relatively specific ligand for D2 dopaminergic receptors, in the rat brain using in vitro homogenate binding and light microscopic quantitative autoradiographic methodologies. Chronic daily injections of cocaine (10 mg/kg, i.p.) for 15 days resulted in a significant decrease in the maximum concentration of sulpiride binding sites in the striatum and a significant increase in the maximum number of these binding sites in the nucleus accumbens. No significant differences in binding affinity were observed in either brain region. These data suggest that chronic cocaine administration may result in differential effects on D2 receptors in the nigro-striatal and mesolimbic dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950865

Source DB:  PubMed          Journal:  Alcohol Drug Res        ISSN: 0883-1386


  19 in total

1.  Adolescent social defeat increases adult amphetamine conditioned place preference and alters D2 dopamine receptor expression.

Authors:  A R Burke; M J Watt; G L Forster
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

2.  Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration.

Authors:  Joseph A Schroeder; Mary R McCafferty; Ellen M Unterwald
Journal:  Synapse       Date:  2009-10       Impact factor: 2.562

3.  Chronic cocaine enhances defensive behaviour in the laboratory mouse: involvement of D2 dopamine receptors.

Authors:  U Filibeck; S Cabib; C Castellano; S Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: II. Dopamine receptors.

Authors:  D K Lim; Z J Yu; B Hoskins; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

5.  Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice.

Authors:  T J Phillips; M G Huson; C S McKinnon
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

6.  Influence of cocaine administration patterns on dopamine receptor regulation.

Authors:  Stéphanie Puig; Nicolas Marie; Nadia Benturquia; Florence Noble
Journal:  Psychopharmacology (Berl)       Date:  2014-02-21       Impact factor: 4.530

7.  Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.

Authors:  H Tsukada; J Kreuter; C E Maggos; E M Unterwald; T Kakiuchi; S Nishiyama; M Futatsubashi; M J Kreek
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

8.  Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Authors:  Gregory T Collins; Yen Nhu-Thi Truong; Beth Levant; Jianyong Chen; Shaomeng Wang; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2011-01-05       Impact factor: 4.530

9.  Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration.

Authors:  M Pecins-Thompson; J Peris
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities.

Authors:  J K Staley; D C Mash
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.